Quantum-Si reports Q2 2026 financial results and updates Proteus timeline
The company extends its launch to Q2 2027, cuts 20% of staff, and raises cash runway into late 2028.
See the latest news and media coverage for Quantum-Si. We track all announcements, press releases, and industry mentions in real time, all in one place.
Single-molecule protein sequencing technology company
quantum-si.comLast updated
In short: Quantum-Si advanced its Proteus platform toward a 2027 launch, regained Nasdaq compliance, and reported financial results.
The company extends its launch to Q2 2027, cuts 20% of staff, and raises cash runway into late 2028.
The company posted $2.4 million in annual revenue, announced a $425,000 list price for its Proteus platform, and provided 2026 guidance targeting approximately $1 million in revenue.
The company targets end-of-2026 for Proteus launch. It demonstrates superior sequencing output and expands amino acid detection capabilities alongside new partnerships.
The company achieved a net loss of $35.7 million and reported on successful Proteus prototype sequencing runs alongside an upcoming investor day.
Quantum-Si develops semiconductor chip based protein sequencing instruments for researchers, and attention on the life sciences tools company has grown.
- Quantum-Si QSI-10.13% delayed its Proteus platform launch to Q2 2027 due to manufacturing consistency issues, causing a ...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced interim ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event...
Track Quantum-Si and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.